Upasana Banerjee, PhD
Clinical Trials Panel
Job Title: Program Manager
Current Employer: UT MD Anderson Cancer Center
Postdoctoral fellowship at University of Texas Health Science Center, Houston, TX (2016)
Ph.D. in Pharmaceutical Sciences, University of Connecticut, Storrs, CT (2014)
B.S. in Pharmacy, Delhi University, New Delhi, India (2009)
Upasana is a clinical research professional with demonstrated history of working in the field of oncology drug discovery for over a decade. Her greatest strengths include startup and operational management of clinical projects, pre-award grants management and establishing productive collaborations with healthcare leaders and communities. She received her doctoral degree from University of Connecticut in 2014. During her tenure as a graduate student, she was vested in the identification of novel small molecule inhibitors of oncogenic Hedgehog signaling pathway. Next, she pursued a postdoctoral fellowship working towards developing isoform selective modulators of EPAC protein as novel therapeutics. Leveraging networking opportunities and instructor led classes available through the postdoctoral association, she landed the role of a clinical study coordinator at Investigational Cancer Therapeutics (Phase 1 clinical research group) at MD Anderson in 2016. Over the years, she has become well versed with the vision and mission of this fast paced department and accordingly assumed additional responsibilities which has allowed her career to grow. In her current role of Program Manager, Upasana oversees the grants program and pre-clinical contracts. She also serves as site relationship manager responsible for expanding the portfolio of potential clinical candidates by liaising with pharma sponsors and CROs.
Most useful skill sets acquired from/for your field:
Being able to grasp complex scientific notions and convey them in layman’s terms, being detailed oriented and organized, willingness to learn constantly.
What I love most about my job:
Ability to maintain a healthy work-life balance while playing a meaningful role within a team responsible for bringing novel and personalized cancer therapy to patients.